Medication info
Tutops Tablet 80/10 mg

Tutops Tablet 80/10 mg

Prescription medicationOral
Ingredient · strength
Telmisartan›80mg / 1 tabletAmlodipine Besylate›13.87mg / 1 tablet
Manufacturer / importer
Ildong Pharmaceutical Co., Ltd.
Appearance
This medication is a double-layered tablet that is oval, convex on both sides, and has a white and light blue color.
Packaging
30 tablets/box [10 tablets/Alu-Alu)x3], 30 tablets/bottle
Approval status
Active

MFDS item code 201605614 · Approved 2016.09.22 · Insurance code 642905730

Summary

Main use
Treatment of essential hypertension not controlled with monotherapy
Who takes it
Adults · Children
Adult dose
The recommended dose of this medicine is 1 tablet once daily, taken with water, regardless of meals. It is recommended that it be taken at the same time each day (e.g., in the morning), if possible. It is recommended that the dose be adjusted using the individual components (telmisartan or amlodipine) before starting this medicine. However, if blood pressure is not controlled with the individual components as described below, switching directly to this medicine may be considered. - 40/5 mg: For patients whose blood pressure is not adequately controlled with amlodipine 5 mg or telmisartan 40 mg. - 80/5 mg: For patients whose blood pressure is not adequately controlled with amlodipine 5 mg or this medicine 40/5 mg. - 40/10 mg: For patients whose blood pressure is not adequately controlled with amlodipine 10 mg. - 80/10 mg: For patients whose blood pressure is not adequately controlled with amlodipine 10 mg or this medicine 40/10 mg. Patients taking telmisartan and amlodipine concomitantly may switch to this medicine (a combination product with the same amounts of each active ingredient) for convenience of administration (limited to this medicine 40/5 mg and 80/10 mg). ○ Patients with renal impairment: No dose adjustment is necessary in patients with mild or moderate renal impairment. For patients with severe renal impairment, however, it is recommended to start treatment at a low dose and increase the dose gradually. Periodic monitoring of serum potassium and creatinine levels is also recommended. ○ Patients with hepatic impairment: The daily dose of telmisartan should not exceed 40 mg in patients with mild or moderate hepatic impairment. ○ Elderly patients: In patients aged 75 years or older, amlodipine clearance is reduced; therefore, treatment should be started at a low dose and the dose increased gradually.
Child dose
○ Pediatric patients: Use of this medicine is not recommended in pediatric patients aged 18 years or younger because its safety and efficacy have not been established.

Ingredients

Manufacturer
Ildong Pharmaceutical Co., Ltd.

Efficacy & effects

Treatment of essential hypertension not controlled with monotherapy

  • Essential Hypertension
View approved original text

This medication can be used to effectively manage blood pressure in patients with essential hypertension whose blood pressure is not adequately controlled by monotherapy with either telmisartan or amlodipine. It helps reduce the risk of cardiovascular diseases and maintain healthy blood pressure levels.

How to take

Adult dose

The recommended dose of this medicine is 1 tablet once daily, taken with water, regardless of meals. It is recommended that it be taken at the same time each day (e.g., in the morning), if possible. It is recommended that the dose be adjusted using the individual components (telmisartan or amlodipine) before starting this medicine. However, if blood pressure is not controlled with the individual components as described below, switching directly to this medicine may be considered. - 40/5 mg: For patients whose blood pressure is not adequately controlled with amlodipine 5 mg or telmisartan 40 mg. - 80/5 mg: For patients whose blood pressure is not adequately controlled with amlodipine 5 mg or this medicine 40/5 mg. - 40/10 mg: For patients whose blood pressure is not adequately controlled with amlodipine 10 mg. - 80/10 mg: For patients whose blood pressure is not adequately controlled with amlodipine 10 mg or this medicine 40/10 mg. Patients taking telmisartan and amlodipine concomitantly may switch to this medicine (a combination product with the same amounts of each active ingredient) for convenience of administration (limited to this medicine 40/5 mg and 80/10 mg). ○ Patients with renal impairment: No dose adjustment is necessary in patients with mild or moderate renal impairment. For patients with severe renal impairment, however, it is recommended to start treatment at a low dose and increase the dose gradually. Periodic monitoring of serum potassium and creatinine levels is also recommended. ○ Patients with hepatic impairment: The daily dose of telmisartan should not exceed 40 mg in patients with mild or moderate hepatic impairment. ○ Elderly patients: In patients aged 75 years or older, amlodipine clearance is reduced; therefore, treatment should be started at a low dose and the dose increased gradually.

Child dose

○ Pediatric patients: Use of this medicine is not recommended in pediatric patients aged 18 years or younger because its safety and efficacy have not been established.

Precautions

This medication can pose serious risks to the fetus during pregnancy, particularly in the second and third trimesters, so it should be discontinued immediately upon confirmation of pregnancy. This drug should not be administered to individuals who are allergic to the active ingredients or related compounds, pregnant women, breastfeeding women, patients with obstructive biliary disease, severe hepatic impairment, severe aortic stenosis, or those in shock. Patients with primary aldosteronism, certain heart valve diseases, impaired liver function, gastrointestinal disorders, renal artery hypertension, severe hypotension, dialysis patients, and the elderly should use this drug with caution. This medication is commonly associated with side effects such as dizziness and peripheral edema, and serious side effects such as syncope can occur infrequently, so any unusual symptoms should prompt immediate consultation with a healthcare professional. This drug should not be used during pregnancy, particularly after the second trimester, as it heightens the risk of renal function impairment in the fetus and other congenital risks. Since this drug lowers blood pressure, patients at risk of hypotension should monitor their blood pressure closely at the start of treatment, and appropriate measures should be taken if hypotensive symptoms appear. Blood potassium levels may increase, so patients with impaired renal function or heart failure should have regular blood tests, and caution is necessary when combined with potassium supplements or potassium-containing drugs. This medication can affect renal function, so patients with renal impairment should frequently check renal function through blood tests. Patients with heart disease may experience increased risks of myocardial infarction or angina when taking this medication, so they should be vigilant for any changes in symptoms. Breastfeeding women are advised against using this medication. Dizziness or drowsiness may occur while taking this medication, so caution is needed when driving or operating hazardous machinery. Interactions may occur when taken with other medications, particularly lithium, digoxin, warfarin, and certain diuretics or anti-inflammatory painkillers, so consultation with a healthcare professional and regular monitoring is necessary. In case of overdose, symptoms such as hypotension, arrhythmia, and dizziness may arise, requiring immediate medical intervention. This medication is not recommended for children or adolescents under 18 years of age, as its safety and efficacy have not been sufficiently established.

Side effects

  • Dizziness
  • peripheral edema
  • syncope
  • upper respiratory infection
  • urinary tract infection
  • cystitis
  • sepsis
  • anemia
  • thrombocytopenia
  • eosinophilia
Show 94 more
  • leukopenia
  • hypersensitivity
  • anaphylactic reaction
  • hyperkalemia
  • hypoglycemia
  • hyperglycemia
  • depression
  • insomnia
  • anxiety
  • confusion
  • drowsiness
  • headache
  • migraine
  • sensory disturbance
  • sensory loss
  • dysgeusia
  • tremor
  • extrapyramidal disorder
  • muscle rigidity
  • visual impairment
  • vertigo
  • tinnitus
  • palpitations
  • bradycardia
  • tachycardia
  • myocardial infarction
  • ventricular tachycardia
  • arrhythmia
  • atrial fibrillation
  • flushing
  • hypotension
  • orthostatic hypotension
  • cough
  • dyspnea
  • rhinitis
  • changes in bowel habits
  • abdominal pain
  • dyspepsia
  • nausea
  • vomiting
  • dry mouth
  • gingival hyperplasia
  • pancreatitis
  • gastritis
  • liver dysfunction
  • hepatic impairment
  • hepatitis
  • jaundice
  • elevated liver enzymes
  • pruritus
  • hyperhidrosis
  • rash
  • alopecia
  • purpura
  • skin discoloration
  • eczema
  • erythema
  • angioedema
  • toxic skin rash
  • drug rash
  • urticaria
  • erythema multiforme
  • exfoliative dermatitis
  • Stevens-Johnson syndrome
  • photosensitivity reaction
  • joint swelling
  • muscle cramps
  • arthralgia
  • myalgia
  • back pain
  • limb pain
  • tendon pain
  • renal dysfunction
  • urinary disorders
  • frequency of urination
  • nocturia
  • erectile dysfunction
  • gynecomastia
  • edema
  • asthenia
  • fatigue
  • chest pain
  • malaise
  • influenza-like illness
  • elevated liver enzymes
  • increased blood creatinine
  • weight gain
  • weight loss
  • increased blood uric acid
  • increased blood creatine phosphokinase
  • decreased hemoglobin
  • interstitial lung disease
  • interstitial pneumonia
  • eosinophilic pneumonia

Not everyone experiences these, and they can vary from person to person.

Storage

This medication should be stored in a tightly closed container that protects it from light, and it is safe to keep at room temperature between 1 to 30 degrees Celsius. Storing it this way helps maintain the medication's efficacy for a long time.

Appearance and packaging

Appearance

This medication is a double-layered tablet that is oval, convex on both sides, and has a white and light blue color.

Package unit

30 tablets/box [10 tablets/Alu-Alu)x3], 30 tablets/bottle

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.